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Highlights 
 Complex mixtures of natural dimycoloyl diarabinoglycerols isolated from mycobacteria have been 
shown to be potent immune signalling agents and potentially valuable antigens in the serodiagnosis of 
mycobacterial infections.  
 We now report the highly stereocontrolled synthesis of diacyl L-glycerol-(1'→1)-β-D-arabinofuranosyl-α-
D-arabinofuranosides based on simple fatty acids and single defined synthetic mycolic acids.  





Abstract: Complex mixtures of natural dimycoloyl diarabinoglycerols isolated from mycobacteria have been shown to be both potent immune 
signalling agents and potentially valuable antigens in the serodiagnosis of mycobacterial infections. We now report the highly stereocontrolled 
synthesis of diacyl L-glycerol-(1'→1)-β-D-arabinofuranosyl-α-D-arabinofuranosides based on simple fatty acids and single defined synthetic mycolic 
acids. NMR analysis confirmed that the synthetic core was identical to that in natural mixtures. 















The cells of Mycobacteria and some other organisms contain complex mixtures of characteristic long chain β-hydroxy acids, mycolic acids 
(MA, 1) (Scheme 1). The proximal group Y is often a cis- or a trans-cyclopropane with a methyl substituent on the adjacent carbon to the 
cyclopropane moiety, in a distal position in relation to the carboxylic group. The distal group X is often a cis-cyclopropane (α-MA), a -
CH(CH3)CH(OCH3)- (methoxy-MA), or a –CH(CH3)CO- fragment (keto-MA). MA may be bound to the wall, generally as penta-arabinose 
tetramycolates.   They may also not be wall bound, when they are generally present as sugar esters such as trehalose dimycolate, trehalose 
monomycolate, glucose and glycerol mycolates (Brennan, 2003). Arabinose mycolate was isolated from firmly bound lipids of 
Mycobacteria over 50 years ago (Azuma et al., 1962, 1963, 1965, 1968 and 1969).  Oligosaccharide fragments from Mycobacterium 
tuberculosis have been extensively studied by mass spectrometry and nuclear magnetic resonance and by degradation (Besra et al., 1995; 
Uenishi et al., 2010; Miyauchi et al., 2011; Daffé et al., 1993; McNeil et al., 1991).  Two-dimensional NMR has been applied in whole cells 
(Lee et al., 2005). The synthesis of the penta-arabinofuranyl and related fragments of M. tuberculosis has been described (Liu et al., 2010; 
Ayers et al., 1998; Mereyala et al., 1998; Backus et al., 2014; Ishiwata et al., 2006). Such fragments have also been found to be of value in 
the treatment of cancer (Sunakawa et al.). Smaller fragments such as glycerol mycolate, (Kremer et al., 2005; Andersen et al., 2009; 
Bhowruth et al., 1999; Hattori et al., 2011 and 2014) and arabinoglycerol mycolate (2), (Watanabe et al., 1999; Mohammed et al., 2015) 
have also been reported and, in the former case, have significant biological activity.  
In 1992, a new glycolipid, 5-mycoloyl-β-arabinofuranosyl-(1→2)-5-mycoloyl-α-arabinofuranosyl-(1→1′)-glycerol (dimycoloyl diarabino-
glycerol, DMAG) (3), was isolated from the Mycobacterium avium – Mycobacterium intracellulare complex (MAC) (Watanabe et al., 1992). 
High IgM titres against the glycolipid 3 were observed in ELISA assays of serum from individuals who were culture positive for MAC infection, 
implying that this serodiagnosis detects the disease in an active phase (Honda et al., 1993). A similar glycolipid mixture has been isolated from 
Mycobacterium bovis Bacille Calmette-Guérin or Mycobacterium marinum and from M. tuberculosis (Rombouts et al., 2012). The DMAG from 
M. marinum (Mma_DMAG) was rich in keto- and methoxy MA rather than α-MA, and lacked trans-cyclopropane MA. It was found to induce 
the secretion of pro-inflammatory cytokines (TNF-α, IL-8, IL-1β) in human macrophage THP-1 cells and to trigger the expression of ICAM-1 
and CD40 cell surface antigens. In addition, various genes encoding pro-inflammatory factors were up-regulated after exposure to 
Mma_DMAG. A range of other genes related to immune and inflammatory responses were modulated, suggesting that DMAG may drive host-
pathogen interactions and participate in the immunopathogenesis of mycobacterial infections (Elass-Rochard et al., 2012). 
        
Scheme 1:  Structures 1 – 5; natural mixtures of mycolic acids comprise a range of different values of a – d. 
We now report the synthesis of a set of diacyl and dimycoloyl diarabinoglycerols by coupling fragments 4 and 5, producing the 
diarabinoglycerol framework as a single β-isomer, followed by esterification and deprotection.  
2. Experimental 
2.1 General 
Chemicals used were obtained from commercial suppliers (Sigma, Aldrich, and Alfa Aesar) or prepared from them by the methods described. Solvents 
which were required to be dry, e.g. ether, tetrahydrofuran were dried over sodium wire and benzophenone under nitrogen, while dichloromethane 
and HMPA were dried over calcium hydride. Petroleum spirit (petrol) was of boiling point 40 – 60 °C. All reagents and solvents used were of reagent 
grade unless otherwise stated. Silica gel (Merck 7736) and silica gel plates used for column and thin layer chromatography were obtained 
from Aldrich; separated components were detected using variously UV light, I2 and phosphomolybdic acid solution in IMS followed by charring. 
Anhydrous MgSO4 was used to dry organic solutions. Infra-red (IR) spectra were carried out on a Perkin-Elmer 1600 F.T.I.R. spectrometer as 
liquid films or KBr disc (solid). Melting points were measured using a Gallenkamp melting point apparatus. NMR spectra were carried out on 











were recorded on a Bruker MALDI-TOF MS to an accuracy of 1 d.p.; accurate mass values were carried out by the EPSRC Mass Spectrometry 
Service in Swansea University or in Bristol University.  
 
2.2   2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2-O-Benzoyl-3,5-O-(tetraiso-propylsiloxane-1,3-diyl)-α-D-arabinofuranoside (8)   
Molecular sieves 4 Å (5.6 g) were added to a stirred solution of α-D-arabinofuranoside (6) (Reddy et al., 2012; D’Souza et al., 2000) (15.4 g, 
0.0255 mol) and 2',3'-di-O-benzyl-L-glycerol (7) (Ashton et al., 1985) (6.9 g, 0.025 mol) in dry CH2Cl2 (25 mL) at rt under nitrogen. The mixture 
was stirred for 30 min then cooled to -35 °C and N-iodosuccinimide (9.38 g, 0.0383 mol) was added, followed by silver 
trifluoromethanesulfonate (1.17 g, 0.00460 mol). The mixture was stirred at -35 °C until the colour turned a red/dark brown colour and TLC 
showed no starting material, then quenched by the addition of triethylamine (2 mL), diluted with CH2Cl2 (50 mL), filtered through celite and 
the solvent was evaporated. Chromatography on silica eluting with hexane/ethyl acetate (10:1) afforded the title compound 8 as a colourless 
thick oil (17 g, 91%) [MALDI–Found (M+Na)+: 773.3; C41H58NaO9Si2, requires: 773.3], []
22
D
+2.6 (c 4.3, CHCl3); δH (400 MHz, CDCl3): 8.01 – 7.97 (2H, 
m), 7.55 (1H, t, J 7.4 Hz), 7.41 (2H, t, J 7.7 Hz), 7.35 – 7.15 (10H, m), 5.41 (1H, br.dd, J 1.4, 4.9 Hz), 4.98 (1H, br.d, J 1.0 Hz), 4.67 (2H, br.s), 4.50 
(2H, br.s), 4.45 (1H, dd, J 5.0, 7.4 Hz), 4.04 – 3.95 (2H, incl. br. dd J 3.0, 9.9 Hz at 3.99), 3.92 (1H, dd, J 5.5, 13.2 Hz), 3.86 – 3.76 (2H, m), 3.67 – 
3.59 (2H, incl. br. dd J 4.2, 10.0 Hz at 3.63), 3.58 (1H, dd, J 5.0, 10.2 Hz), 1.32 – 0.75 (28H, m); δC (101 MHz, CDCl3): 165.5, 138.7, 138.3, 133.2, 
129.7, 128.4, 128.3, 128.2, 127.8, 127.6, 127.5, 127.4, 105.6, 84.4, 81.2, 76.2, 73.4, 72.3, 70.3, 67.7, 61.8, 31.6, 22.6, 17.5, 17.4, 17.3, 17.0, 
16.9, 13.4, 13.2, 12.8, 12.5; νmax: 3065, 3031, 2945, 2868,1717, 1105, 884, 712 cm-1. 
 
2.3 2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2-O-allyl-3-O-benzyl-5-O-tert-butyldiphenylsilyl-α-D-arabinofuranoside (9) 
(i) Sodium methoxide in methanol (10 mL, 0.1 M) was added to a stirred solution of compound (8) (15.6 g, 0.0207 mol) in dry CH3OH:CH2Cl2 
(25 mL, 1:1) at rt and the mixture was stirred for 0.5 h then neutralized with Amberlite IR-120 (H+), the resin was filtered off and the solvent 
was removed; chromatography on silica eluting with petrol/ethyl acetate (5:1) afforded 2',3'-di-O-benzyl-L-glycerol-(1'→1)-3,5-O-(tetraisopropylsiloxane-
1,3-diyl)-α-D-arabinofuranoside as a thick colourless oil (12 g, 89%) [Found–MALDI (M+Na)+ : 669.3, C34H54NaO8Si2, requires 669.3], []
20
D -40 (c 0.10, CHCl3) 
which showed δH (400 MHz, CDCl3): 7.35 – 7.17 (10H, m), 4.79 (1H, br.d, J 2.4 Hz), 4.63 (2H, br.s), 4.49 (2H, br.s), 4.14 – 4.04 (2H, m), 3.89 (1H, 
dd, J 3.1, 12.7 Hz), 3.86 (1H, br.d, J 3.7 Hz), 3.84 – 3.79 (1H, m), 3.77 (1H, br.dd, J 3.7, 7.2 Hz), 3.72 (1H, p, J 4.8 Hz), 3.57 (2H, d, J 4.8 Hz), 3.54 
(1H, dd, J 4.4, 10.5 Hz), 1.80 (1H, br s), 1.12 – 0.72 (28H, m); δC (101 MHz, CDCl3): 138.5, 138.4, 128.3, 128.3, 127.8, 127.7, 127.6, 107.5, 82.6, 
80.8, 76.9, 73.4, 72.2, 70.2, 67.9, 61.4, 31.6, 22.6, 17.4, 17.3, 17.1, 17.05, 17.0, 13.5, 13.1, 12.8, 12.5; νmax: 3402,3062, 2946, 2867, 1467, 1035, 
884, 695 cm-1.  
 
(ii) A solution of the above α-D-arabinofuranoside (11.9 g, 0.0183 mol) in dry DMF (20 mL) was added dropwise to a stirred suspension of NaH 
(0.88 g, 0.036 mol, 60% dispersion in mineral oil) at 0 °C under nitrogen. The mixture was stirred for 10 min, when allyl bromide (2.66 g, 1.90 
mL, 0.022 mol) was added, stirred at 0 °C for 2 h, then quenched by slow addition of CH3OH (1 mL) and evaporated under reduced pressure 
to give an oil. This was diluted with ethyl acetate (100 mL), and washed with water (50 mL), brine (50 mL), dried and evaporated under reduced 
pressure. Chromatography on silica eluting with petrol/ethyl acetate (5:1) gave 2',3'-di-O-benzyl-L-glycerol-(1'→1)-2-O-allyl-3,5-O-
(tetraisopropyl-siloxane-1,3-diyl)-α-D-arabinofuranoside as a colourless thick oil (9.5 g, 75%) [Found–MALDI (M+Na)+: 709.3, C37H58NaO8Si2, 
requires:709.3], [] 22
D
+72 (c 0.10, CHCl3); δH (400 MHz, CDCl3): 7.44 – 7.05 (10H, m), 5.81 (1H, ddt, J 5.4, 10.6, 17.3 Hz), 5.20 (1H, dd, J 1.6, 
17.3 Hz), 5.09 (1H, dd, J 1.4, 10.6 Hz), 4.84 (1H, br.d, J 2.4 Hz), 4.63 (2H, br.s), 4.49 (2H, br.s), 4.14 (1H, dd, J 6.0, 8.3 Hz), 4.05 – 3.93 (2H, m), 
3.92 – 3.81 (3H, m), 3.80 – 3.77 (2H, incl. br. dd J 3.5, 8.5 Hz at 3.78), 3.76 – 3.70 (1H, m), 3.64 – 3.55 (2H, incl. br. dd J 4.1, 10.7 Hz at 3.58), 
3.54 (1H, dd, J 3.4, 9.3 Hz), 1.11 – 0.83 (28H, m); δC (101 MHz, CDCl3): 138.6, 138.3, 134.3, 128.3, 128.2, 127.7, 127.6, 127.55, 127.5, 116.8, 
106.0, 89.5, 80.5, 77.1, 76.1, 73.4, 72.1, 71.4, 70.4, 67.5, 61.5, 17.5, 17.3, 17.2, 17.1, 17.05, 17.0, 13.5, 13.1, 12.8, 12.5; νmax: 3082, 3069, 2927, 
2867. 
(iii) Tetrabutylammonium fluoride (26.2 mL, 0.0904 mol, 1.0 M) was added dropwise to a stirred solution of the above α-D-arabino-furanoside 
(9.0 g, 0.01 mol) in anhydrous THF (25 mL) at 0 °C under nitrogen. The mixture was allowed to reach rt and stirred for 2 h, then diluted with 
ethyl acetate (100 mL), washed with sat. aq. NH4Cl (50 mL) and brine (50 mL). The organic layer was dried and concentrated to give a residue; 
chromatography on silica eluting with hexane/ethyl acetate (3:1) gave 2',3'-di-O-benzyl-L-glycerol-(1'→1)-2-O-allyl-α-D-arabino-furanoside as 
a colourless thick oil (5.5 g, 95%) [Found–MALDI (M+Na)+: 467.2, C25H32NaO7, requires: 467.2], []
20
D +80 (c 0.10, CHCl3); which showed δH 
(400 MHz, CDCl3): 7.33 – 7.19 (10H, m), 5.81 (1H, ddt, J 5.6, 10.8, 17.2 Hz), 5.22 (1H, dd, J 1.5, 17.2 Hz), 5.14 (1H, dd, J 1.3, 10.8 Hz), 5.00 (1H, 
br.s), 4.61 (1H, d, J 11.9 Hz), 4.57 (1H, d, J 11.9 Hz), 4.48 (2H, br.s), 4.04 – 3.92 (4H, m), 3.84 – 3.77 (2H, incl. br. dd J 5.7, 10.3 Hz at 3.81), 3.72 
(1H, br.dd, J 4.8, 9.7 Hz), 3.68 (1H, br.d, J 3.1 Hz), 3.63 (1H, dd, J 3.7, 11.8 Hz), 3.58 – 3.54 (1H, m), 3.53 – 3.49 (2H, incl. br.d, J 5.1 Hz at 3.52), 
1.80 (2H, br s); δC (101 MHz, CDCl3): 138.1, 137.9, 133.6, 128.4, 128.3, 127.8, 127.75, 127.7, 117.9, 105.6, 86.9, 86.5, 76.5, 75.3, 73.5, 72.1, 












(iv) tert-Butylchlorodiphenylsilane (9.2 g, 0. 033 mol) was added to a stirred solution of the above α-D-arabinofuranoside (15 g, 0.033 mol) in 
dry DMF (100 mL), followed by the addition of imidazole (5.7 g, 0.084 mol) at 0 °C under nitrogen. The mixture was allowed to reach rt and 
stirred for 25 min, then diluted with ethyl acetate (100 mL) and water (25 mL). The aqueous layer was re-extracted with ethyl acetate (2×100 
mL). The combined organic layers were washed with water (100 mL), brine (100 mL), dried and the solvent was evaporated under reduced 
pressure. Chromatography on silica eluting with hexane/ ethyl acetate (4:1) afforded 2',3'-di-O-benzyl-L-glycerol-(1'→1)-2-O-allyl-5-O-tert-
butyldiphenylsilyl-α-D-arabinofuranoside as a colourless thick oil (15 g, 65%) [MALDI–Found (M+NH4)+: 700.3661; C41H54O7SiN requires: 700.3664], []
22
D
+26.5  (c 1.27, CHCl3); δH (400 MHz, CDCl3): 7.66 – 7.55 (4H, m), 7.41 – 7.17 (16H, m), 5.77 (1H, ddt, J 5.5, 10.7, 17.2 Hz), 5.18 (1H, dd, J 1.0, 
17.2 Hz), 5.11 (1H, dd, J 0.5, 10.7 Hz), 4.95 (1H, br.s), 4.62 (1H, d, J 12.1 Hz), 4.58 (1H, d, J 12.1 Hz), 4.48 (2H, br.s), 4.11 – 3.98 (2H, incl. br. dd 
J 3.5, 9.6 Hz at 4.03), 3.97 – 3.87 (2H, incl. br. d J 5.4 Hz at 3.93), 3.83 – 3.75 (3H, incl. br. dd J 5.5, 10.5 Hz at 3.79), 3.74 – 3.69 (1H, m), 3.66 
(1H, dd, J 6.5, 10.2 Hz), 3.60 – 346 (3H, incl. br. q J 4.7 Hz at 3.54), 2.62 (1H, br s), 1.02 (9H, s); δC (101 MHz, CDCl3): 138.3, 138.0, 135.6, 135.5, 
134.0, 133.3, 133.2, 129.7, 128.4, 128.3, 127.75, 127.7, 127.65, 127.6, 127.55, 117.3, 106.0, 87.8, 84.9, 76.6, 76.5, 73.4, 72.0, 70.6, 69.9, 66.8, 
64.3, 26.8, 19.2; νmax: 3445, 3069, 3031, 2930, 2859,1590, 1471, 1110, 858, 740 cm-1. 
(v) A solution of the above α-D-arabinofuranoside (9.7 g, 0.014 mol) in dry DMF (100 mL) was added dropwise to a stirred suspension of NaH 
(0.68 g, 0.028 mol, 60% dispersion in mineral oil) at 0 °C under nitrogen atmosphere. The mixture was stirred for 30 min, then benzyl bromide 
(2.5 mL, 3.6 g, 0.021 mol) in dry DMF (5 mL) was added. The mixture was stirred at rt for 10 h then quenched slowly with CH3OH (10 mL) and 
H2O (15 mL) and diluted with ether (200 mL). The aqueous layer was extracted with ether (2×100 mL). The combined extracts were washed 
with water (100 mL), brine (100 mL), dried and the solvent was evaporated under reduced pressure. Chromatography on silica eluting with 
petrol/ethyl acetate (5:1) gave the title compound 9 as a colourless thick oil (8.1 g, 72%) [MALDI–Found (M+NH4)+: 790.4132; C48H60O7SiN 
requires: 790.4134], [] 22
D
+28 (c 3.9, CHCl3); δH (400 MHz, CDCl3): 7.79 – 756 (4H, incl. br. dd  J 3.9, 10.8 Hz at 7.66), 7.47 – 7.14 (21H, m), 5.84 
(1H, ddt, J 5.5, 10.7, 17.2 Hz), 5.24 (1H, dd, J 1.3, 17.2 Hz), 5.16 (1H, dd, J 0.9, 10.7 Hz), 5.01 (1H, br.s), 4.70 (1H, d, J 12.0 Hz), 4.66 (1H, d, J 
12.0 Hz), 4.59 (1H, d, J 11.9 Hz), 4.54 – 4.48 (3H, m), 4.13 (1H, br.q, J 4.6 Hz), 4.03 – 3.89 (4H, m), 3.85 (1H, dd, J 5.1, 10.2 Hz), 3.82 – 3.73 (3H, 
incl. br. dd J 4.8, 8.1 Hz at 3.79), 3.67 – 3.56 (3H, m), 1.04 (9H, s); δC (101 MHz, CDCl3): 138.6, 138.3, 138.0, 135.7, 135.6, 134.1, 133.5, 133.4, 
129.6, 129.5, 128.3, 128.2, 127.7, 127.65, 127.6, 127.55, 127.5, 127.45, 127.4, 117.2, 106.4, 88.0, 77.0, 73.3, 72.1, 72.0, 70.6, 70.3, 67.0, 63.7, 
26.8, 19.3; νmax: 3068, 3031, 2929, 2859, 1588, 1454, 1027, 823, 738 cm-1. 
2.4 2',3'-Di-O-benzyl-L-glycerol-(1'→1)-3-O-benzyl-5-p-methoxybenzyl-α-D-arabinofuranoside (5)  
(i)  Tetrabutylammonium fluoride (7.0 mL, 7.0 mmol, 1.0 M) was added dropwise to a stirred solution of α-D-arabinofuranoside (9) (5.2 g, 0.0067 mol) 
in anhydrous THF (50 mL) at 0 °C under nitrogen. The mixture was allowed to reach rt and stirred for 16 h then diluted with ethyl acetate (100 
mL) and water (50 mL). The aqueous layer was re-extracted with ethyl acetate (3×50 mL). The combined organic layers were washed with sat. 
aq. NH4Cl (50 mL), brine (50 mL), dried and concentrated. Chromatography on silica eluting with petrol/ethyl acetate (5:1) to give 2',3'-di-O-
benzyl-L-glycerol-(1'→1)-2-O-allyl-3-O-benzyl-α-D-arabinofuranoside as a colourless thick oil (3.3 g, 91%) [MALDI–Found (M+NH4)+: 552.2948; 
C32H42O7N requires: 552.2956], []
22
D
+36 (c 3.3, CHCl3); δH (400 MHz, CDCl3): 7.38 – 7.28 (15H, m), 5.87 (1H, ddt, J 5.6, 10.7, 17.2 Hz), 5.27 (1H, 
dd, J 1.5, 17.2 Hz), 5.20 (1H, dd, J 1.1, 10.7 Hz), 5.03 (1H, br.s), 4.70 (2H, br.s), 4.66 (1H, d, J 11.8 Hz), 4.58 – 4.49 (3H, m), 4.13 (1H, br.p, J 3.4 
Hz), 4.01 (1H, br.dd, J 4.4, 11.8 Hz), 3.99 – 3.95 (2H, incl. br. d  J 10.6 Hz at 3.98), 3.94 (1H, br.dd, J 2.6, 6.2 Hz), 3.86 (1H, dd, J 5.2, 10.3 Hz), 
3.82 (1H, dd, J 5.3, 9.6 Hz), 3.79 (1H, br.d, J 9.7 Hz), 3.67 – 3.63(2H, incl. br. dd J 6.3, 7.4 Hz at 3.64), 3.63 – 3.59 (2H, incl. br. d J 10.5 Hz at 
3.62), 1.82 (1H, br s); δC (101 MHz, CDCl3): 138.6, 138.2, 137.8, 133.9, 128.4, 128.35, 128.3, 127.8, 127.75, 127.7, 127.6, 127.5, 117.6, 106.4, 
87.6, 82.8, 82.2, 76.9, 73.4, 72.3, 72.2, 70.7, 70.1, 67.1, 62.2; νmax: 3453, 3063, 3031, 2923, 2870, 1603, 1453, 1064, 850, 739 cm-1.  
(ii)  The above α-D-arabinofuranoside (3.1 g, 0.0057 mol) in dry DMF (10 mL) was added dropwise to a stirred suspension of NaH (0.25 g, 0.010 
mol, 60% dispersion in mineral oil) at 0 °C under nitrogen, then stirred for 30 min, when freshly prepared p-methoxybenzyl bromide (1.4 g, 
0.0069 mol) was added. The mixture was stirred at 0 °C for 2 h then quenched with slow addition of CH3OH (1 mL) and evaporated; the oily 
residue was diluted with ethyl acetate (50 mL). The organic layer was washed with water (25 mL), brine (25 mL), dried and evaporated. 
Chromatography on silica eluting with petrol/ethyl acetate (5:1) gave 2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2-O-allyl-3-O-benzyl-5-p-methoxy-benzyl-α-D-
arabinofuranoside as a thick colourless oil (2.9 g, 76%) [MALDI–Found (M+NH4)+: 672.3526; C40H50O8N requires: 672.3531], [] 22D +41 (c 1.6, CHCl3); 
δH (400 MHz, CDCl3): 7.37 – 7.26 (15H, m), 7.24 (2H, d, J 8.7 Hz), 6.86 (2H, d, J 8.6 Hz), 5.86 (1H, ddt, J 5.5, 10.7, 17.2 Hz), 5.25 (1H, dd, J 1.6, 
17.2 Hz), 5.18 (1H, dd, J 1.3, 10.7 Hz), 5.03 (1H, br.s), 4.71 (1H, d, J 12.1 Hz), 4.68 (1H, d, J 12.1 Hz), 4.61 (1H, d, J 11.9 Hz), 4.54 (3H, br.s), 4.51 
(1H, d, J 11.7 Hz), 4.47 (1H, d, J 11.7 Hz), 4.22 – 4.15 (1H, m), 4.03 – 3.91 (3H, m), 3.88 (1H, dd, J 5.2, 10.5 Hz), 3.86 (1H, br.d, J 6.5 Hz), 3.84 – 
3.75 (4H, incl. s at 3.8 for OCH3), 3.66 – 3.58 (4H, m), 3.55 (1H, dd, J 5.2, 10.7 Hz); δC (101 MHz, CDCl3): 138.7, 138.3, 138.0, 134.1, 130.2, 129.4, 
128.8, 128.4, 128.3, 127.75, 127.7, 127.6, 127.5, 127.45, 117.4, 113.7, 106.4, 88.1, 83.7, 80.8, 73.4, 73.0, 72.2, 70.8, 70.4, 69.3, 67.2, 55.3; 
νmax: 3064, 3030, 2912, 2864, 1612, 1513, 1454, 1106, 820, 738 cm-1. 
(iii) Palladium (II) chloride (0.30 g, 0.0017 mol) was added to a stirred solution of the above α-D-arabinofuranoside (5.7 g, 0.0087 mol) in dry 











pressure. Chromatography on silica eluting with petrol/ethyl acetate (4:1) gave the title compound 5 as a pale yellow thick oil (4.5 g, 84%) [MALDI–
Found (M+NH4)+: 632.3209; C37H46O8N requires: 632.3218], []
22
D
+60 (c 4.6, CHCl3); δH (400 MHz, CDCl3): 7.38 – 7.26 (15H, m), 7.23 (2H, d, J 
8.5 Hz), 6.89 (2H, d, J 8.6 Hz), 5.03 (1H, br.s), 4.74 (1H, d, J 12.1 Hz), 4.68 (1H, d, J 12.1 Hz), 4.66 (1H, d, J 11.9 Hz), 4.58 (1H, d, J 11.9 Hz), 4.51 
(2H, br.s), 4.49 (1H, d, J 11.7 Hz), 4.44 (1H, d, J 11.7 Hz), 4.26 (1H, br.d, J 2.4 Hz), 4.18 (1H, d, J 10.8 Hz), 3.89 (1H, dd, J 5.4, 10.4 Hz), 3.87 (1H, 
br.d, J 3.1 Hz), 3.85 – 3.79 (4H, incl. s at 3.82 for OCH3), 3.68 – 3.63 (3H, m), 3.61 (1H, dd, J 5.5, 10.2 Hz), 3.49 (1H, dd, J 2.1, 10.4 Hz), 3.39 (1H, 
d, J 10.8 Hz); δC (101 MHz, CDCl3): 159.5, 138.8, 138.4, 137.8, 129.5, 129.1, 128.4, 128.3, 128.2, 127.75, 127.7, 127.65, 127.55, 127.45, 127.4, 
113.9, 109.4, 85.4, 83.6, 77.5, 76.9, 73.4, 73.3, 72.2, 71.9, 70.4, 69.4, 67.4, 55.2; νmax: 3433, 3063, 3031, 2912, 2867, 1611, 1513, 1454, 1248, 




Molecular sieves 4 Å (5 g) was added to a stirred solution of -D-arabinofuranoside (5) (4.3 g, 0.0069 mol) and α-D-arabinofuranoside (4) (11.4 g, 
0.0174 mol) in dry CH2Cl2 (50 mL) at rt under nitrogen. The mixture was stirred for 30 min then cooled to -78 °C and N-iodosuccinimide (6.4 g, 0.026 
mol) was added followed by the addition of silver trifluoromethanesulfonate (0.71 g, 0.0028 mol). The mixture was stirred until the colour turned red/dark 
brown at -60 °C, quenched with triethylamine (4 mL) until the colour turned yellow, then diluted with CH2Cl2 (100 mL) and filtered through celite. The 
solvent was evaporated. The residue was purified by chromatography on silica eluting with hexane/ethyl acetate (4:1) affording the title compound 10 as 
a yellow thick oil (6.9 g, 86%) [MALDI–Found (M+NH4)+:1162.6495; C63H100O13Si3N requires: 1162.6497], []
22
D
+4.5 (c 0.97, CHCl3); δH (400 MHz, CDCl3): 
7.28 – 7.18 (15H, m), 7.15 (2H, d, J 8.5 Hz), 6.78 (2H, d, J 8.5 Hz), 4.96 (1H, br.s), 4.79 (1H, br.d, J 4.3 Hz), 4.63 (1H, d, J 12.0 Hz), 4.59 (2H, d, J 12.0 Hz), 
4.44 (2H, br.s), 4.43 (1H, d, J 12.0 Hz), 4.39 (2H, br.s), 4.34 (1H, br.dd, J 5.7, 7.3 Hz), 4.20 – 4.17 (1H, br.m), 4.15 (1H, dd, J 4.7, 9.2 Hz), 4.12 (1H, br.t, 
J 5.1 Hz), 3.87 (1H, d, J 5.7 Hz), 3.86 (1H, d, J 6.8 Hz), 3.84 – 3.76 (3H, m), 3.75 – 3.70 (4H, incl. s at 3.73 for OCH3), 3.56 (1H, dd, J 3.9, 9.7 Hz), 3.53 (1H, br.d, 
J 5.3 Hz), 3.51 – 3.47 (2H, incl. br. dd J 4.6, 10.5 Hz at 3.49), 3.45 (1H, dd, J 5.9, 10.8 Hz), 1.04 – 0.92 (49H, m); δC (101 MHz, CDCl3): 159.1, 138.8, 138.4, 
138.0, 130.2, 129.3, 128.3, 128.25, 128.2, 127.7, 127.65, 127.6, 127.5, 127.4, 127.3, 113.7, 106.2, 100.6, 85.9, 84.4, 82.0, 81.5, 79.4, 79.1, 77.05, 73.3, 72.9, 
72.2, 72.15, 70.6, 69.8, 67.4, 66.6, 55.2, 18.0, 17.95, 17.6, 17.5, 17.4, 17.3, 17.2, 17.1, 17.0, 16.9, 13.4, 13.3, 13.0, 12.7, 12.4; νmax: 3064, 3031, 2943, 2867, 
1513,1248, 736, 695 cm-1. 
 
2.6  2',3'-Di-O-benzyl-L-glycerol-(1'→1)-β-D-arabinofuranosyl-(1→2)-3-O-benzyl-5-p-methoxybenzyl-α-D-arabinofuranoside (11) 
TBAF (17.1 mL, 0.0202 mol, 1.0 M) was added dropwise with stirring to α-D-arabinofuranoside (10) (6.5 g, 0.0056 mol) in dry THF (100 mL) at 
0 °C under nitrogen. The mixture was stirred at rt for 6 h, then diluted with ethyl acetate (100 mL) and water (10 mL). The aqueous layer was 
re-extracted with ethyl acetate (3×25 mL). The combined organic layers were washed with sat. aq. NH4Cl (25 mL), brine (25 mL), and concentrated; 
chromatography on silica eluting with dichloro-methane/methanol (20:1) gave the title compound 11 as a thick colourless oil (4.0 g, 95%) 
[MALDI–Found (M+NH4)+: 764.3639; C42H54O12N requires: 764.3641], []
24
D
+16 (c 0.50, CHCl3); δH (400 MHz, CDCl3): 7.28 – 7.17 (15H, m), 7.15 
(2H, d, J 8.6 Hz), 6.79 (2H, d, J 8.6 Hz), 4.96 (1H, br.s), 4.94 (1H, br.d, J 4.7 Hz), 4.60 (2H, br.s), 4.56 (1H, d, J 11.9 Hz), 4.44 (3H, br.s), 4.40 (1H, 
d, J 11.6 Hz), 4.33 (1H, d, J 11.6 Hz), 4.23 (1H, m), 4.06 (1H, br.p, J 3.6 Hz), 4.01 (1H, dd, J 2.7,  6.1 Hz), 3.95 (1H, t, J 7.2 Hz), 3.87 (1H, br.dd, J 
5.9, 10.6 Hz), 3.79 (1H, br.dd, J 4.8, 10.5 Hz), 3.76 (1H, br.dd, J 3.3, 6.8 Hz), 3.73 – 3.69 (4H, incl. s at 3.7 for OCH3), 3.61 – 3.47 (6H, m), 3.39 
(1H, dd, J 3.9, 10.9 Hz), 2.70 (2H, br s), 2.28 (1H, br s); δC (101 MHz, CDCl3): 159.3, 138.5, 138.2, 137.8, 129.8, 129.7, 128.4, 128.35, 128.3, 
127.8, 127.7, 127.6, 127.55, 127.5, 113.8, 106.2, 101.0, 86.5, 82.9, 82.4, 81.2, 78.1, 76.9, 75.0, 73.4, 73.1, 72.3, 72.2, 70.1, 68.6, 67.3, 62.3, 55.3; 




tert-Butylchlorodiphenylsilane (1.39 mL, 1.47 g, 0.00535 mol) was added with stirring to arabinofuranoside (11) (4.0 g, 0.005 mol) in dry DMF 
(5 mL), followed by the addition of imidazole (0.73 g, 0.010 mol) at 0 °C under nitrogen. The mixture was allowed to reach rt, stirred for 30 
min, then diluted with ethyl acetate (25 mL) and water (5 mL). The aqueous layer was re-extracted with ethyl acetate (2×25 mL). The combined organic 
layers were washed with water (10 mL), brine (10 mL), dried and evaporated under reduced pressure. Chromatography on silica eluting 
chloroform/methanol (20:1) afforded the title compound as a colourless thick oil (4.1 g, 77%) [MALDI–Found (M+NH4)+: 1002.4816; C58H72O12SiN, 
requires: 1002.4818], [] 22
D
-6.3 (c 0.38, CHCl3); δH (400 MHz, CDCl3): 7.69 – 7.63 (4H, m), 7.46 – 7.16 (21H, m), 7.11 (2H, dd, J 2.9, 8.0 Hz), 6.85 (2H, d, 
J 8.0 Hz), 5.03 (1H, br.d, J 4.5 Hz), 5.02 (1H, br.s), 4.69 (1H, d, J 12.0 Hz), 4.66 (1H, d, J 12.0 Hz), 4.56 – 4.48 (4H, m), 4.45 (1H, d, J 11.6 Hz), 4.40 (1H, d, 
J 11.6 Hz), 4.31 – 4.29 (1H, m), 4.25 (1H, d, J 11.7 Hz), 4.14 (1H, br.p, J 5.1 Hz), 4.01 – 3.84 (4H, m), 3.82 (1H, br.dd, J 3.8, 9.1 Hz), 3.79 – 3.75 (4H, incl. 












Hz), 2.43 (1H, d, J 9.4 Hz), 2.16 (1H, d, J 2.7 Hz), 1.07 (9H, s); δC (101 MHz, CDCl3): 159.2, 138.6, 138.3, 137.8, 135.8, 135.7, 135.6, 135.5, 133.1, 133.0, 
130.0, 129.95, 129.9, 129.6, 129.5, 128.4, 128.35, 128.3, 128.2, 128.0, 127.9, 127.85, 127.8, 127.7, 127.65, 127.6, 127.55, 127.5, 113.8, 106.3, 100.8, 
85.9, 83.8, 81.6, 81.4, 78.2, 77.4, 77.0, 73.4, 73.0, 72.3, 72.2, 70.2, 69.1, 67.3, 66.1, 55.3, 26.9, 19.2; νmax: 3438, 3067, 3031, 2930, 2859, 1612, 1513, 




α-D-arabinofuranoside (section 4.7) (4.0 g, 0.0040 mol) in dry DMF (5 mL) was added dropwise to a stirred suspension of NaH (0.39 g, 0.016 mol, 
60% dispersion in mineral oil) at 0 °C under nitrogen. The mixture was stirred for 0.5 h then benzyl bromide (1.44 mL, 2.08 g, 0.012 mol) in dry DMF (5 mL) 
was added. The mixture was stirred at rt for 10 h, then quenched with CH3OH (1 mL) and H2O (5 mL) and diluted with ether (25 mL). The aqueous 
layer was extracted with ether (2×25 mL). The combined organic layers were washed with water (25 mL), brine (25 mL), dried and evaporated. 
Chromatography on silica eluting with petrol/ethyl acetate (4:1) gave the title compound 12 as a colourless thick oil (4.3 g, 90%) [MALDI–Found (M+NH4)+: 
1182.5751; C72H84O12SiN requires: 1182.5757], []
22
D
-11 (c 0.38, CHCl3); δH (400 MHz, CDCl3): 7.68 – 7.64 (4H, m), 7.42 – 7.16 (31H, m), 7.08 (2H, dd, J 1.6, 
8.0 Hz), 6.85 (2H, d, J 8.0 Hz), 5.08 (1H, d, J 4.4 Hz), 5.04 (1H, br.s), 4.70 (1H, d, J 12.1 Hz), 4.66 (1H, d, J 12.1 Hz), 4.64 (2H, br.s), 4.56 (1H, d, J 11.7 Hz), 4.52 
(2H, br.s), 4.48 (1H, d, J 11.7 Hz), 4.44 (2H, d, J 11.5 Hz), 4.41 (2H, d, J 11.5 Hz), 4.29 (1H, br.d, J 1.9 Hz), 4.20 (1H, br.d, J 5.9 Hz), 4.17 (2H, br.dd, J 5.0, 6.1 
Hz), 4.11 (1H, br.q, J, 6.5 Hz), 4.05 (1H, br.dd, J 4.5, 6.1 Hz), 3.89    (1H, dd, J 5.2, 10.4 Hz), 3.84 – 3.78 (6H, incl. s at 3.79 for OCH3), 3.61 (3H, br.dd, J 4.8, 9.4 
Hz), 3.53 (1H, br.dd, J 2.8, 9.5 Hz), 3.49 (1H, br.dd, J 4.7, 9.5 Hz), 1.05 (9H, s);   δC (101 MHz, CDCl3): 159.1, 138.7, 138.4, 138.2, 137.9, 137.7, 135.6, 135.5, 
133.2, 133.1, 130.3, 129.8, 129.3, 128.4, 128.3, 128.2, 128.1, 127.9, 127.8, 127.75, 127.7, 127.6, 127.55, 127.5, 127.4, 113.7, 106.0, 100.3, 85.4, 84.6, 84.1, 
84.0, 82.0, 81.6, 77.1, 73.3, 72.8, 72.4, 72.3, 72.25, 72.2, 70.4, 69.9, 67.2, 66.2, 55.2, 26.8, 19.2; νmax: 3065, 3031, 2930, 2860, 1612, 1513, 1248, 738, 699 
cm-1. 
2.9    2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-β-D-arabinofuran- osyl-(1→2)-3-O-benzyl-5-p-methoxybenzyl-α-D-arabinofuranoside (13) 
TBAF (3.5 mL, 0.0038 mol, 1.0 M) was added dropwise to a stirred solution of α-D-arabinofuranoside (12) (4.1 g, 0.0035 mol) in dry THF (25 
mL) at 0 °C under nitrogen. The mixture was allowed to reach rt and stirred for 6 h then diluted with ethyl acetate (15 mL) and water (5 mL). The 
aqueous layer was re-extracted with ethyl acetate (3×50 mL). The combined organic layers were washed with sat. aq. NH4Cl (25 mL), brine (25 mL), dried 
and concentrated; chromatography on silica eluting with petrol /ethyl acetate (5:2) gave the title compound 13 as a colourless thick oil (3.0 g, 93%) 
[MALDI–Found (M+NH4)+: 944.4574; C56H66O12N requires: 944.4580], []
22
D
-7.1 (c 0.79, CHCl3); δH (400 MHz, CDCl3): 7.29 – 7.18 (25H, m), 7.16 (2H, d, 
J 8.7 Hz), 6.78 (2H, d, J 8.7 Hz), 4.97 (1H, d, J 4.5 Hz), 4.95 (1H, br.d, J 1.1 Hz), 4.64 (1H, d, J 11.7 Hz), 4.60 (2H, br.s), 4.53 (1H, d, J 11.5 Hz), 4.51 (1H, d, 
J 11.5 Hz), 4.47 – 4.43 (4H, m), 4.39 (1H, d, J 11.9 Hz), 4.38 (1H, d, J 11.9 Hz), 4.35 (1H, d, J 11.7 Hz), 4.21 (1H, br.dd, J 1.4, 3.5 Hz), 4.18 (1H, d, J 6.8 Hz), 
4.09 (1H, br.p, J 4.1 Hz ), 4.02 (1H, br.dd, J 3.5, 6.5 Hz), 3.95 (1H, dd, J 4.5, 7.3 Hz), 3.93 – 3.88 (1H, m), 3.79 (1H, dd, J 5.2, 10.4 Hz), 3.74 – 3.68 (4H, incl. 
s at 3.71 for OCH3), 3.59 – 3.50 (5H, m), 3.48 (1H, br.d, J 3.7 Hz), 3.43 (1H, dd, J 4.9, 10.8 Hz), 2.22 (1H, br.dd, J 5.1, 7.8 Hz); δC (101 MHz, CDCl3): 159.2, 
138.6, 138.3, 138.1, 137.9, 137.6, 130.0, 129.5, 128.5, 128.45, 128.4, 128.3, 128.2, 128.0, 127.9, 127.8, 127.75, 127.7, 127.65, 127.6, 127.55, 127.5, 
113.8, 106.1, 100.1, 86.3, 84.1, 83.3, 82.0, 81.0, 80.7, 77.0, 73.4, 73.0, 72.6, 72.4, 72.2, 70.3, 69.1, 67.4, 63.4, 55.2; νmax: 3491, 3063, 3031, 2925, 2869, 
1612, 1513, 1454, 1248, 738, 699 cm-1. 
 
2.10  2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-β-D-arabinofuran-osyl-(1→2)-3-O-benzyl-α-D-arabinofuranoside (14) 
Cerium ammonium nitrate (CAN) (3.5 g, 0.0064 mol) was added with stirring to furanoside (13) (2.0 g, 0.002 mol) in CH3CN: H2O (9:1, 15 mL) 
at 0 °C. The mixture was allowed to reach rt, stirred for 1 h, then diluted with chloroform (25 mL), washed with aq. NaHCO3 (15 mL), dried 
and evaporated under reduced pressure. Chromatography on silica eluting with petrol/ethyl acetate (5:2) gave the title compound 14 as a 
colourless thick oil (1.5 g, 89%) [MALDI–Found (M+Na)+: 829.4; C48H54NaO11 requires: 829.4], [] 21D -4.3 (c 0.83, CHCl3); δH (400 MHz, CDCl3): 7.64 – 
6.67 (25H, m), 4.97 (1H, br.d, J 4.6 Hz), 4.95 (1H, br.s), 4.67 (1H, d, J 11.6 Hz), 4.64 (2H, br.s), 4.62 (1H, d, J 11.6 Hz), 4.55 (1H, d, J 11.6 Hz), 
4.50 – 4.46 (5H, m), 4.2 – 4.17 (2H, br. dd J 5.6, 8.1 Hz), 4.16 (1H, br.dd, J 2.2, 5.6 Hz), 4.09 – 4.04 (1H, m), 4.00 (1H, dd, J 4.6, 7.3 Hz), 3.97 – 
3.92 (1H, m), 3.80 (1H, dd, J 5.2, 10.2 Hz), 3.76 (1H, br.d, J 6.4 Hz), 3.73 (1H, br.dd, J 3.9, 8.3 Hz), 3.63 (1H, dd, J 2.9, 10.2 Hz), 3.60 – 3.48  (5H, 
m), 1.30 (2H, br s); δC (101 MHz, CDCl3): 138.5, 138.2, 137.9, 137.8, 137.4, 128.5, 128.4, 128.35, 128.3, 128.2, 128.1, 128.0, 127.8, 127.7, 
127.65, 127.6, 127.55, 127.5, 106.3, 100.5, 86.4, 84.0, 83.0, 82.7, 81.9, 80.4, 76.9, 73.3, 72.6, 72.5, 72.3, 72.2, 70.1, 67.2, 63.2, 62.0; νmax: 3463, 
3063, 3031, 2922, 2872, 1454, 1107, 738, 698 cm-1. 
2.11 2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-5-O-methane-sulfonyl-β-D-arabinofuranosyl-(1→2)-3-O-benzyl-5-O-methane-sulfonyl-α-D-
arabino-furanoside (15) 
Methanesulfonyl chloride (1.98 g, 1.36 mL, 17.1 mmol) and DMAP (0.10 g, 0.86 mmol) were added to a stirred solution of α-D-











H2O (3 mL). The organic layer was diluted with CH2Cl2 (10 mL) and washed with 1N HCl (4×10 mL), sat. aq. NaHCO3 (4×10 mL), dried and 
evaporated under reduced pressure to give a thick oil. Chromato-graphy on silica eluting with petrol/ethyl acetate (4:1) gave compound 15 as a 
colourless thick oil (1.4 g, 85%) [MALDI–Found (M+Na)+: 985.3109; C50H58NaO15S2 requires: 985.3115]; []
22
D
+2.8 (c 1.3, CHCl3); δH (400 MHz, CDCl3): 7.36 – 
7.16 (25H, m), 5.01 (1H, br.d, J 4.4 Hz), 4.93 (1H, br.s), 4.70 (1H, d, J 11.7 Hz), 4.67 (1H, d, J 11.7 Hz), 4.63 (2H, br.s), 4.58 (1H, d, J 11.7 Hz), 
4.51 (1H, d, J 11.7 Hz), 4.46 (4H, br.s), 4.32 (1H, br.q, J 4.6 Hz), 4.25 – 4.13 (5H, m), 4.13 – 4.07 (3H, m), 4.00 (1H, br.dd, J 4.4, 6.9 Hz), 3.80 (1H, 
dd, J 5.2, 10.3 Hz), 3.74 (1H, br.p, J 5.1 Hz), 3.60 – 3.50 (3H, incl. br. dd, J 4.6, 7.2 at 3.56), 2.85 (3H, s), 2.84 (3H, s); δC (101 MHz, CDCl3): 138.5, 
138.2, 137.7, 137.6, 137.2, 128.6, 128.5, 128.4, 128.35, 128.3, 128.1, 128.0, 127.95, 127.9, 127.8, 127.75, 127.7, 127.6, 127.55, 127.5, 106.4, 
101.2, 85.9, 83.5, 81.1, 80.9, 78.4, 76.9, 73.3, 72.7, 72.6, 72.4, 72.3, 69.9, 69.8, 69.0, 67.3, 37.5, 37.4; νmax: 3087, 3031, 2929, 2867, 1606, 
1454, 1046,738, 697 cm-1.  
2.12   2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-5-O-alkanoate-β-D-arabinofuranosyl-(1→2)-3-O-benzyl-5-O-alkanoate-α-D-arabino-
furanosides (16a-e) 
General procedure: Cesium hydrogencarbonate was added to a stirred solution of α-D-arabinofuranoside (15) and the selected fatty acid in dry 
THF:DMF (5:1, 1 mL) at rt under nitrogen . The mixture was stirred at 70 °C for 4 days then diluted with ethyl acetate (25 mL) and water (5 mL). The 
aqueous layer was re-extracted with ethyl acetate (2×10 mL). The combined organic layers were washed with water (10 mL) and brine (10 mL) 
and evaporated under reduced pressure to give a thick oil. Chromatography on silica eluting with hexane/ethyl acetate (5:1) afforded the title 
compounds (16a-e). Full analytical data is presented here for 16a; that for 16b – 16e is provided in the Supplementary Data. 
(i) 2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-5-O-palmitate-β-D-arabinofuranosyl-(1→2) -3-O-benzyl-5-O-palmitate-α-D-arabinofuranoside (16a): 
CsHCO3 (66 mg, 0.34 mmol), α-D-arabinofuranoside (15) (33.0 mg, 0.034 mmol) and palmitic acid (22 mg, 0.085 mmol) gave (16a) as a colourless 
thick oil (41 mg, 92%) [MALDI–Found (M+Na)+: 1305.8; C80H114NaO13 requires: 1305.8], []
22
D -7.6 (c 0.58, CHCl3); δH (400 MHz, CDCl3): 7.37 – 7.16 (25H, 
m), 5.01 (1H, d, J 4.2 Hz), 4.95 (1H, br.s), 4.66 (1H, d, J 11.6 Hz), 4.63 (3H, br.s), 4.56 (1H, d, J 11.6 Hz), 4.48 (1H, d, J 11.6 Hz), 4.47 (2H, br.s), 4.45 (1H, 
d, J 11.8 Hz), 4.41 (1H, d, J 11.8 Hz), 4.30 (1H, br.d, J 2.0 Hz), 4.25 – 4.15 (3H, m), 4.11 (1H, br.dd, J 3.1, 6.6 Hz), 4.09 – 4.01 (3H, m), 3.99 (1H, dd, J 4.3, 6.6 
Hz), 3.90 (1H, br.dd, J 2.5, 5.8 Hz), 3.82 (1H, dd, J 5.2, 10.4Hz), 3.74 (1H, br.p, J 5.0 Hz), 3.61 – 3.50 (3H, incl. br. dd J 4.7, 8.5 Hz at 3.56), 2.33 
– 2.21 (2H, m), 2.18 (2H, dt, J 2.1, 7.4 Hz), 1.64 – 1.01 (52H, m), 0.84 (6H, t, J 6.8 Hz); δC (101 MHz, CDCl3): 173.5, 173.4, 138.6, 138.3, 137.8, 
137.7, 137.4, 128.5, 128.4, 128.35, 128.3, 128.0, 127.8, 127.75, 127.7, 127.65, 127.6, 127.5, 106.1, 100.5, 85.6, 84.3, 83.8, 82.5, 80.1, 78.9, 
73.4, 72.6, 72.5, 72.4, 72.3, 70.2, 67.3, 66.0, 63.7, 34.0, 31.9, 29.7, 29.65, 29.6, 29.5, 29.4, 29.35, 29.3, 29.25, 29.2, 29.1, 24.9, 24.8, 22.7, 14.1; 
νmax: 3065, 3031, 2924, 2853, 1741, 1732, 1455, 1114, 737, 698 cm-1. 
2.13 L-Glycerol-(1'→1)-5-O-alkanoate-β-D-arabinofuranosyl-(1→2)-5-O-alkanoate-α-D-arabinofuranosides (17) 
General procedure: Palladium hydroxide on activated charcoal was added to a stirred solution of α-D-arabinofuranoside (16a-e) in 
CH2Cl2:MeOH:THF (1:1:1.5, 1 mL) at rt under hydrogen. The mixture was stirred for 36 h, filtered through celite and evaporated under reduced 
pressure to give a residue. Chromatography on silica eluting with chloroform/methanol (10:1) afforded furanosides (17a-e).   
(i) L-Glycerol-(1'→1)-5-O-palmitate-β-D-arabinofuranosyl-(1→2)-5-O-palmitate-α-D-arabinofuranoside (17a): Pd(OH)2-C/20% (25 mg, 0.75 fold 
by weight) and furanoside (16a) (33 mg, 0.025 mmol) gave (17a) as a colourless thick oil (18 mg, 82%) [MALDI–Found (M+Na)+: 855.5804; 
C45H84NaO13 requires: 855.5810]; []
21
D +14 (c 0.30, CHCl3), which showed δH (400 MHz, CDCl3+few drops CD3OD): 5.06 (1H, br.d, J 4.5 Hz), 
5.02 (1H, br.d, J 1.9 Hz), 4.45 (1H, dd, J 7.2, 11.9 Hz), 4.38 – 3.30 (1H, m), 4.28 (1H, br.dd, J 4.1, 6.8 Hz), 4.26 – 4.21 (1H, m), 4.20 – 4.15 (2H, 
incl. br. dd, J 1.9, 9.6 Hz at 4.18), 4.15 – 4.10 (2H, m), 4.07 (2H, incl. br. dd, J 5.4, 8.3 Hz at 4.07), 4.04 (1H, br.d, J 7.0 Hz), 4.00 (1H, dd, J 4.8, 
10.3 Hz), 3.91 – 3.85 (2H, m), 3.77 (2H, dd, J 6.0, 10.7 Hz), 3.71 (1H, br.d, J 2.9 Hz), 3.67 (2H, br.t, J 6.0 Hz), 2.36 (4H, t, J 7.6 Hz), 1.46 – 1.08 
(53H, m), 0.89 (6H, t, J 6.8 Hz); δC (101 MHz, CDCl3+few drops CD3OD): 173.5, 173.4, 138.6, 138.3, 137.8, 137.7, 137.4, 128.5, 128.4, 128.35, 
128.3, 128.0, 127.8, 127.75, 127.7, 127.65, 127.6, 127.5, 106.1, 100.5, 85.6, 84.3, 83.8, 82.5, 80.1, 78.9, 77.0, 73.4, 72.6, 72.5, 72.4, 72.3, 70.2, 
67.3, 66.0, 63.7, 34.0, 31.9, 29.7, 29.65, 29.6, 29.5, 29.45, 29.4, 29.3, 29.25, 29.2, 29.1, 24.9, 24.8, 22.7, 14.1; νmax: 3436, 2918, 2850, 1738, 
1643, 1469, 1219, 1116, 1041, 927 cm-1. 
(ii) L-Glycerol-(1'→1)-5-O-stearate-β-D-arabinofuranosyl-(1→2)-5-O-stearate-α-D-arabinofuranoside (17b): Pd(OH)2-C/20% (34 mg, 0.75 fold by 
weight) and α-D-arabino-furanoside (16b) (45 mg, 0.033 mmol) gave (17b) as a colourless thick oil (24 mg, 81%) [MALDI–Found (M+Na)+: 
911.6430; C49H92NaO13 requires: 911.6436], []
25
D -3.4 (c 0.71, CHCl3); δH (400 MHz, CDCl3+few drops CD3OD): 5.01 (1H, br.d, J 4.3 Hz), 5.00 (1H, 
br.s), 4.33 – 4.29 (1H, m), 4.27 (1H, br.d, J 5.7 Hz), 4.20 – 4.15 (2H, m), 4.13 (1H, br.d, J 7.0 Hz), 4.04 (1H, dd, J 5.9, 10.6 Hz), 4.00 (1H, br.dd, J 2.6, 
6.6 Hz), 3.98 – 3.88 (3H, incl. br. dd J 4.9, 9.0 Hz at 3.96), 3.86 – 3.78 (1H, m), 3.74 (1H, dd, J 5.8, 10.6 Hz), 3.63 (1H, br.dd, J 3.9, 11.8 Hz), 3.6 – 3.53 
(2H, incl. br.dd, J 3.0, 10.8 Hz at 3.58), 2.33 (4H, t, J 7.5 Hz), 1.36 – 1.17 (65H, m), 0.86 (6H, t, J 6.3 Hz); δC (101 MHz, CDCl3): 173.5, 173.3, 138.6, 
138.3, 137.8, 137.7, 137.4, 128.5, 128.4, 128.3, 128.2, 128.0, 127.8, 127.7, 127.65, 127.6, 127.55, 127.5, 106.1, 100.4, 85.6, 84.3, 83.8, 82.5, 80.1, 
78.8, 77.0, 73.4, 72.5, 72.4, 72.3, 72.2, 70.2, 67.3, 65.9, 63.7, 34.0, 31.9, 29.7, 29.65, 29.6, 29.5, 29.4, 29.35, 29.3, 29.2, 29.15, 29.1, 24.9, 24.8, 












(iii) L-Glycerol-(1'→1)-5-O-behenate-β-D-arabinofuranosyl-(1→2)-5-O-behenate-α-D-arabinofuranoside (17c): Pd(OH)2-C/ 20% (75 mg, 0.75 fold 
by weight) and furanoside (16c) (100 mg, 0.0688 mmol) gave (17c) as a colourless thick oil (60 mg, 87%) [MALDI–Found (M+Na)+: 1023.7682; 
C57H108NaO13 requires: 1023.7688], []
22
D -2.3 (c 0.44, CHCl3), which showed δH (400 MHz, CDCl3+few drops CD3OD): 4.97 (1H, br.d, J 4.7 Hz), 4.96 
(1H, br.s), 4.30 – 4.21 (2H, incl. br. dd J 8.4, 11.2 Hz at 4.25), 4.16 (1H, dd, J 3.2, 11.9 Hz), 4.14 – 4.06 (2H, m), 4.03 – 3.97 (2H, m), 3.96 – 3.88    (3H, 
m), 3.78 (1H, br.p, J 5.1 Hz), 3.71 (1H, dd, J 6.0, 10.4 Hz), 3.63 – 3.59 (1H, m), 3.57     (1H, dd, J 4.3, 11.5 Hz), 3.53 (1H, dd, J 4.8, 11.2 Hz), 2.31 (4H, 
t, J 7.6 Hz), 1.34 – 1.14 (81H, m), 0.83 (6H, t, J 6.6 Hz); δC (126 MHz, CDCl3+few drops CD3OD): 174.2, 173.9, 105.9, 101.9, 88.5, 80.3, 80.1, 75.8, 
75.5, 70.4, 69.5, 65.5, 63.6, 63.2, 34.0, 33.9, 31.8, 29.5, 29.45, 29.4, 29.3, 29.2, 29.15, 29.1, 29.0, 24.7, 22.5, 13.8; νmax: 3419, 2956, 2917, 1738, 
1732, 1464, 1215, 1171, 1048, 881, 720 cm-1. 
 
(iv) L-Glycerol-(1'→1)-5-O-(R)-2-((R)-1-hydroxydocosyl)hexacosanoate-β-D-arabinofuranosyl-(1→2)-5-O-(R)-2-((R)-1-hydroxydocosyl)hexa-
cosanoate-α-D-arabinofuranoside (17d): Pd(OH)2-C/20% (23 mg, 0.75 fold by weight) and α-D-arabino-furanoside (16d) (30 mg, 0.013 mmol) 
gave (17d) as a colourless thick oil (17 mg, 74%) [MALDI–Found (M+Na)+: 1728.5; C105H204NaO15 requires: 1728.5], []
22
D +8 (c 0.3, CHCl3); δH 
(400 MHz, CDCl3+few drops CD3OD): 4.98 (1H, br.d, J 5.7 Hz), 4.97 (1H, br.s), 4.40 (1H, dd, J 4.7, 11.6 Hz), 4.34 (1H, dd, J 4.8, 11.4 Hz), 4.22 
(1H, dd, J 5.6, 11.6 Hz), 4.20 (1H, dd, J  6.4, 12.0 Hz), 4.13 (1H, dd, J 6.1, 10.7 Hz), 4.10 (1H, br.q, J 6.9 Hz), 4.05 – 3.98 (4H, incl. br. d J 11.2 Hz 
at 4.02), 3.85 – 3.76 (1H, m), 3.71 (1H, dd, J 6.4, 10.6 Hz), 3.68 – 3.62 (2H, br.m), 3.61 (1H, d, J 4.1 Hz), 3.57 (1H, dd, J 4.2, 9.6 Hz), 3.54 (1H, 
br.dd, J 3.2, 10.3 Hz), 2.46 – 2.37 (2H, m), 1.64 – 1.01 (171H, m), 0.86 (12H, t, J 6.8 Hz); δC (101 MHz, CDCl3+few drops CD3OD): 175.1, 175.0, 
105.8, 101.5, 87.6, 80.7, 79.5, 77.2, 76.4, 76.1, 72.8, 72.5, 70.4, 69.5, 65.4, 63.7, 63.3, 63.2, 53.3, 52.6, 34.8, 34.7, 31.9, 29.7, 29.6, 29.55, 29.5, 
29.45, 29.4, 29.3, 29.2, 29.1, 27.4, 27.3, 25.4, 25.2, 22.6, 14.0; νmax: 3416, 2927, 2854, 1728, 1719, 1466, 1215, 1121, 1044, 759, 669 cm-1. 
(v) L-Glycerol-(1'→1)-5-O-(R)-2-((R)-1-hydroxy-18-((1R,2S)-2-((17S,18S)-17-methoxy-18-methylhexatriacontyl)cyclopropyl)-
octadecyl)tetracosanoate-β-D-arabinofuranosyl-(1→2)-5-O-(R)-2-((R)-1-hydroxy-18-((1R,2S)-2-((17S,18S)-17-methoxy-18-methylhexatria-
contyl)cyclopropyl)octadecyl)-tetracosanoate-α-D-arabinofurano-side (17e): Pd(OH)2-C/20% (33 mg, 0.75 fold by weight) was added with 
stirring to compound (16e) (43 mg, 0.013 mmol) in CH2Cl2:MeOH (1:1, 1 mL) at rt under hydrogen. After 36 h, the mixture was filtered through celite 
and evaporated to give a residue. Chromatography on silica eluting with chloroform/methanol (10:1) gave (17e) as a colourless thick oil (27 mg, 73%) 
[MALDI–Found (M+Na)+: 2793.6; C179H348NaO17 requires: 2793.6], []
22
D +13 (c 0.36, CHCl3); δH (400 MHz, CDCl3+few drops CD3OD): 4.98 (1H, br.d, J 
4.7 Hz), 4.82 (1H, br.s), 4.40 (1H, dd, J 4.4, 12.2 Hz), 4.37 – 4.31 (2H, incl. br. dd J 4.7, 11.6 Hz at 4.34), 4.22 (1H, dd, J 5.6, 11.5 Hz), 4.15 (1H, br.dd, J 
5.6, 11.7 Hz), 4.10 (1H, br.dd, J 4.1, 9.0 Hz), 4.07 – 3.94 (6H, br.m), 3.89 (1H, br.dd, J 2.6, 4.7 Hz), 3.85 – 3.77 (1H, m), 3.72 (1H, dd, J 5.5, 11.5 Hz), 3.69 
– 3.51 (6H, m), 3.38 (1H, dd, J 4.2, 8.5 Hz), 3.32 (6H, s), 2.99 – 2.90 (2H, m), 2.47 – 2.37 (2H, m), 1.66 – 0.96 (288H, m), 0.86 (12H, t, J 6.9 Hz), 0.83 (6H, 
d, J 6.9 Hz), 0.66 – 0.58 (4H, m), 0.53 (2H, dt, J 4.1, 8.6 Hz), -0.36 (2H, br.q, J 5.1 Hz); δC (101 MHz, CDCl3+few drops CD3OD): 175.1, 175.0, 105.8, 101.5, 
87.7, 85.5, 80.6, 79.5, 77.2, 76.4, 76.0, 72.6, 72.4, 70.3, 69.3, 65.4, 63.3, 63.1, 57.6, 53.2, 52.6, 35.2, 32.2, 31.8, 30.4, 30.1, 29.8, 29.7, 29.6, 29.5, 29.3, 
29.2, 29.1, 29.0, 28.6, 27.4, 27.35, 27.3, 26.0, 25.3, 25.2, 22.6, 15.6, 14.7, 13.9, 10.8; νmax: 3397,  2920, 2851, 1730, 1467, 1171, 1099, 1046, 721 cm-1. 
 
2.14 2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-5-O-mycolate-β-D-arabinofuranosyl-(1→2)-3-O-benzyl-5-O-mycolate-α-D-arabinofuranoside (18f-h): 
General procedure:  1-Ethyl-3-(3-dimethylaminopropyl)carbodi-imide hydrochloride (EDCI) in dry CH2Cl2 (1 mL) was added to a stirred solution 
of furanoside (14); molecular sieves 4 Å, DMAP and mycolic acids (f-h) (R’ = TBDMS) in dry CH2Cl2 (1 mL) at rt under nitrogen and stirred for 5 
days. The precipitate was washed with CH2Cl2 (10 mL), the solvent was evaporated and the residue was purified by chromato-graphy on silica 





((1S,2R)-2-((S)-20-methyl-19-oxooctatriacontyl)cyclopropyl)hexa-decyl)hexacosanoate-α-D-arabinofuranoside (18f): EDCI (77 mg; 0.40 mmol), 
molecular sieves 4 Å (50 mg), arabinofuranoside (14) (33 mg, 0.040 mmol),  DMAP    (49 mg; 0.40 mmol) and (R)-2-((R)-1-((tert-butyldimethylsilyl)oxy)-16-
((1S,2R)-2-((S)-20-methyl-19-oxooctatriacontyl)-cyclopropyl)hexadecyl)hexacosanoic acid (108 mg, 0.0790 mmol)29 gave the title compound as a colourless 
thick oil (0.13 g, 97%) [MALDI–Found (M+Na)+: 3496.1; C228H406NaO17Si2 requires: 3496.1], []
21
D +4.2 (c 0.38, CHCl3); δH (400 MHz, CDCl3): 7.38 – 7.18 (25H, 
m), 5.03 (1H, br.d, J 4.2 Hz), 4.97 (1H, br.s), 4.72 (1H, d, J 11.6 Hz), 4.68 (3H, d, J 11.6 Hz), 4.62 (1H, d, J 11.7 Hz), 4.56 – 4.48 (4H, m), 4.43 (1H, d, J 11.7 Hz), 4.37 
(1H, br.d, J 2.0 Hz), 4.29 – 4.11 (6H, m), 4.06 (1H, t, J 6.0 Hz), 4.00 (1H, br.dd, J 4.3, 6.5 Hz), 3.96 – 3.81 (4H, m), 3.78 (1H, br.p, J 4.7 Hz), 3.67 – 3.54 (3H, incl. br. 
dd J 4.4, 10.4 Hz at 3.60), 2.53 (4H, incl. sextet J 6.8 Hz at 2.53), 2.42 (4H, dt, J 1.0, 7.2 Hz), 1.61 – 1.12 (288H, m), 1.06 (6H, d, J 6.9 Hz), 0.89 (12H, t, J 6.8 Hz), 0.85 
(9H, s), 0.84 (9H, s), 0.71 – 0.62    (4H, m), 0.57 (2H, dt, J 4.1, 8.4 Hz), 0.04 (3H, s), 0.02 (3H, s), 0.01 (3H, s), -0.01 (3H, s), -0.32 (2H, br.q, J 5.1 Hz);   δC (101 MHz, 
CDCl3): 215.2, 174.3, 174.1, 138.6, 138.3, 137.9, 137.7, 137.5, 128.5, 128.4, 128.3, 128.2, 128.0, 127.9, 127.8, 127.7, 127.65, 127.6, 127.5, 127.4, 105.9, 100.2, 











29.75, 29.7, 29.65, 29.6, 29.55, 29.5, 29.45, 29.4, 29.35, 29.3, 28.7, 27.8, 27.7, 27.4, 27.3, 25.9, 25.8, 24.0, 23.9, 23.7, 22.7, 16.4, 15.8, 14.1, 10.9, -4.4, -4.5,     -
4.7, -4.8; νmax: 3088, 3063, 2922, 2852, 1739, 1713, 1465, 1115, 758, 698 cm-1. 
 
2.15 De-protection of silyl group in MA fragment: (18f-h)  
General procedure: TBAF (1.0 M in THF) was added dropwise with stirring to compounds (18f-h)   in dry THF (1 mL) at 0 °C under nitrogen then 
diluted with ethyl acetate (10 mL) and water (1 mL). The aqueous layer was re-extracted with ethyl acetate (3×10 mL). The combined organic 
layers were washed with sat.aq. NH4Cl (5 mL), brine (5 mL), dried and the concentrated. Chromatography on silica eluting with hexane /ethyl 




hexadecyl)hexacosanoate-α-D-arabinofuranoside (16f): TBAF (0.56 mL, 1.9 mmol, 1.0 M) and  arabinofuranoside (18f)  (98 mg, 0.028 mmol) gave 
the title compound as a colourless thick oil (45 mg, 38%); [MALDI–Found (M+Na)+: 3267.9; C216H378NaO17 requires: 3267.9], []
22
D +7.1 (c 0.34, CHCl3);  δH (400 
MHz, CDCl3): 7.39 – 7.22 (25H, m), 5.01 (1H, br.d, J 4.3 Hz), 4.97 (1H, br.s), 4.71 (2H, d, J 11.5 Hz), 4.67 (2H, m), 4.62 (1H, d, J 11.5 Hz), 4.56 – 4.50 (3H, m), 4.51 
(1H, d, J 11.6 Hz), 4.45 (1H, d, J 11.6 Hz), 4.32 (1H, br.d, J 1.7 Hz), 4.30 – 4.21 (5H, m), 4.17 – 4.08 (2H, incl. br. p J 6.0 Hz at 4.12), 4.02 (1H, br.dd, J 4.4, 6.3 Hz), 
3.99 – 3.93 (1H, m), 3.84 (1H, dd, J 5.3, 10.3 Hz), 3.81 – 3.76 (1H, br.p, J 5.3 Hz), 3.59 (5H, incl. br. dd , J 4.5, 10.8 Hz at 3.59), 2.56 – 2.46 (4H, incl. sextet , J 6.8 Hz 
at 2.51), 2.42 (4H, dt, J 1.1, 7.6 Hz),  1.65 – 1.11 (290H, m), 1.06 (6H, d, J 6.9 Hz), 0.89 (12H, t, J 6.8 Hz), 0.71 – 0.61 (4H, m), 0.60 – 0.53 (2H, dt, J 4.0, 8.5 Hz), -0.32 
(2H, br.q, J 5.1 Hz); δC (101 MHz, CDCl3): 215.2, 175.0, 138.5, 138.3, 137.7, 137.3, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.8, 127.75, 127.7, 127.6, 
127.5, 105.9, 100.4, 85.5, 84.4, 83.7, 82.8, 80.3, 78.9, 77.2, 73.4, 72.7, 72.6, 72.5, 72.4, 72.2, 72.1, 70.2, 67.2, 66.1, 63.7, 51.9, 51.6, 46.3, 41.1, 35.4, 35.3, 33.0, 
31.9, 30.3, 30.2, 29.8, 29.75, 29.7, 29.65, 29.6, 29.55, 29.5, 29.45, 29.4, 29.35, 29.3, 29.2, 28.7, 27.5, 27.4, 27.3, 25.7, 23.7, 22.7, 16.4, 15.8, 14.1, 10.9; νmax: 3501, 
3063, 2920, 2852, 1736, 1714, 1465, 1116, 757, 698 cm-1. 
 
2.16    L-Glycerol-(1'→1)-5-O-mycolate-β-D-arabinofuranosyl-(1→2)-5-O-mycolate-α-D-arabinofuranoside (17f-h) : 
General procedure 
Palladium hydroxide on activated charcoal was added to a stirred solution of α-D-arabinofuranoside (16f-h) in CH2Cl2:MeOH (1:1, 1 mL) at rt under 
hydrogen. The mixture was stirred for 36 h then filtered off through celite and the solvent was evaporated under reduced pressure to give a 
residue which was purified by column chromatography on silica eluting with chloroform/methanol (10:1) affording the title compounds (17f-




D-arabinofuranoside (17f): (Pd(OH)2-C/20% (26 mg, 0.75 fold by weight) and α-D-arabinofuranoside (16f) (35 mg, 0.010 mmol) gave (17f) as a 
colourless thick oil (22 mg, 71%) [MALDI–Found (M+Na)+: 2817.6; C181H348NaO17, requires: 2817.6], []
22
D +7.4 (c 0.38, CHCl3); δH (400 MHz, 
CDCl3+few drops CD3OD): 4.97 (1H, br.d, J 4.4 Hz), 4.96 (1H, br.s), 4.38 (1H, dd, J 4.7, 11.6 Hz), 4.33 (1H, br.dd, J 6.9, 11.4 Hz), 4.20 (1H, dd, J 
6.0, 11.5 Hz), 4.18 (1H, dd, J 5.4, 11.5 Hz), 4.11 (1H, br.q, J 5.5 Hz), 4.08 – 3.92 (5H, m), 3.82 – 3.75 (1H, br.m), 3.69 (1H, br.dd, J 6.3, 10.5 Hz), 
3.66 – 3.62 (3H, m), 3.57 (1H, br.dd, J 4.5, 11.4 Hz), 3.52 (1H, dd, J 3.4, 10.4 Hz), 2.60 – 2.40 (4H, incl. sextet J 6.8 Hz at 2.48), 2.38 (4H, br.t, 
7.3 Hz), 1.67 – 1.05 (295H, m), 1.01 (6H, d, J 6.9 Hz), 0.84 (12H, t, J 6.8 Hz), 0.65 – 0.56 (4H, m), 0.52 (2H, dt, J 4.1, 8.5 Hz), -0.37 (2H, br.q, J 5.1 
Hz); δC (101 MHz, CDCl3+few drops CD3OD): 215.9, 175.1, 175.0, 105.8, 101.5, 87.6, 80.7, 79.5, 77.2, 76.4, 76.1, 72.7, 72.5, 70.3, 69.4, 65.4, 
63.2, 53.3, 52.6, 46.3, 41.1, 34.8, 34.7, 32.9, 31.8, 30.2, 30.1, 29.7, 29.6, 29.55, 29.5, 29.45, 29.4, 29.35, 29.3, 29.25, 29.2, 29.1, 29.0, 28.6, 
27.4, 27.3, 27.2, 25.3, 25.2, 23.6, 22.6, 16.2, 15.7, 14.0, 10.8; νmax: 3420,  2919, 2851, 1733, 1714, 1467, 1120, 1046, 721 cm-1. 
 
2.17 2',3'-Di-O-acetyl-L-glycerol-(1'→1)-2,3-di-O-acetyl-5-O-behenate-β-D-arabinofuranosyl-(1→2)-3-O-acetyl-5-O-behenate-α-D-arabino-
furanoside (DMAG penta-acetate analogue from 16c) 
Acetic anhydride (0.02 g, 0.20 mmol, 0.02 mL) was added to a stirred solution of α-D-arabinofuranoside (16c) (20 mg, 0.019 mmol) in dry 
pyridine (2 mL) at rt and stirred for 18 h under nitrogen. The solvent was evaporated and the product was purified by chromatography eluting with 
petrol/ethyl acetate (2:1) to afford the title compound (23) (20 mg, 83%) [MALDI–Found (M+Na)+: 1233.8210; C67H118NaO18 requires: 1233.8216], []
23
D -13 (c 0.62, CHCl3), which showed δH (400 MHz, CDCl3): 5.40 (1H, br.d, J 4.7 Hz), 5.34 (1H, dd, J 5.3, 6.3 Hz), 5.21 (1H, br.p, J 4.8 Hz), 4.95 (2H, 
br.dd, J 4.7, 6.6 Hz), 4.91 (1H, br.s), 4.37 (1H, dd, J 4.6, 11.6 Hz), 4.29 (1H, dd, J 4.4, 7.6 Hz), 4.27 – 4.10 (7H, m), 3.82 (1H, dd, J 5.2, 11.0 Hz), 3.60 












173.4, 173.3, 170.6, 170.4, 170.2, 170.1, 169.9, 105.0, 99.4, 83.9, 80.6, 79.1, 77.5, 75.6, 69.8, 65.3, 65.2, 63.6, 62.5, 34.1, 34.0, 31.9, 31.6, 29.7, 




EDCI (13.6 mg, 0.070 mmol) in dry CH2Cl2 (1 mL) was added dropwise to a stirred solution of α-D-arabinofuranoside (13) (13.2 mg, 0.0142 
mmol), DMAP (8.6 mg, 0.070 mmol) and behenic acid (7.1 mg, 0.020 mmol) in dry CH2Cl2 (1 mL) at 0 °C under nitrogen, and stirred for 48 h. 
The precipitate was washed with CH2Cl2 (10 mL). The solvent was evaporated and the residue was purified by chromatography eluting with 
hexane/ethyl acetate (5:1) to give compound (19) as a colourless thick oil (15 mg, 85%) [Found (M+NH4)+: 1266.7800; C78H108O13N, requires: 
1266.7815], []
22
D -2.2 (c 0.92, CHCl3); δH (400 MHz, CDCl3): 7.30 – 7.17 (25H, m), 7.15 (2H, d, J 8.6 Hz), 6.77 (2H, d, J 8.6 Hz), 5.00 (1H, br.d, J 
4.1 Hz), 4.95 (1H, br.s), 4.61 (1H, d, J 12.1 Hz), 4.60 (2H, br.s), 4.58 (1H, d, J 12.1 Hz), 4.51 (1H, d, J 11.6 Hz), 4.46 – 4.41 (3H, m), 4.37 (3H, br.d, 
J 11.7 Hz), 4.36 (1H, d, J 11.7 Hz), 4.25 (1H, br.d, J 1.9 Hz), 4.17 – 4.10 (2H, m), 4.07 – 3.98 (3H, m), 3.95 (1H, br.q, J 6.6 Hz), 3.89 (1H, br.dd, J 
2.4, 6.0 Hz), 3.80 (1H, dd, J 5.1, 10.4 Hz), 3.74 – 3.68 (4H, incl. s at 3.72 for OCH3), 3.57 – 3.50 (3H, incl. br. dd, J 5.0, 8.5 Hz at 3.53), 3.49 – 3.42 
(2H, incl. br. dd J 4.2, 11.1 Hz at 3.47), 2.13 (2H, dt, J 3.6, 7.7 Hz), 1.53 – 1.02 (38H, m), 0.81 (3H, t, J 6.7 Hz); δC (101 MHz, CDCl3): 173.4, 159.2, 
138.7, 138.3, 138.0, 137.8, 137.5, 130.2, 129.4, 128.5, 128.4, 128.3, 128.2, 128.0, 127.9, 127.8, 127.7, 127.65, 127.6, 127.55, 127.5, 127.4, 
113.7, 106.0, 100.5, 85.9, 84.4, 83.8, 82.6, 81.5, 78.9, 77.0, 73.4, 72.9, 72.5, 72.4, 72.3, 72.2, 70.3, 69.6, 67.2, 66.0, 55.2, 34.0, 31.9, 29.8, 29.7, 
29.65, 29.6, 29.5, 29.4, 29.3, 29.1, 24.8, 22.7, 14.1; νmax: 3062, 3031, 2924, 2859, 1741, 1612, 1513, 1454, 1248, 1110,738, 699 cm-1. 
 
2.19    2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-5-O-behen-ate-β-D-arabinofuranosyl-(1→2)-3-O-benzyl-5-O-(2R)-2-(1-((tert-
butyldimethylsilyl)oxy)-16-((1S,2R)-2-((S)-20-methyl-19-oxo-octatria-contyl)cyclopropyl)hexadecyl) hexacosanoate)-α-D-arabinofuran-oside 
(20)  
(i) Cerium ammonium nitrate (CAN) (13 mg, 0.023 mmol) was added to a stirred solution of compound (19) (15 mg, 0.012 mmol) in CH3CN:H2O:THF 
(9:1:0.2, 1 mL)at 0 °C. The mixture was allowed to reach room temperature and stirred at ambient temperature for 16 h. The mixture was diluted with 
chloroform (20 mL), washed with aq. NaHCO3 (10 mL), dried and the solvent was evaporated under reduced pressure. Column chromatography on silica 
eluting with petrol/ethyl acetate (4:1) gave 2',3'-di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-5-O-behenate-β-D-arabinofuranosyl-(1→2)-3-O-benzyl-α-D-
arabinofuranoside as a colourless thick oil (8.4 mg, 62%) [NSI–Found (M+Na)+: 1151.7; C70H96NaO12, requires: 1151.7]; []
22
D -11 (c 0.27, CHCl3), which 
showed δH (400 MHz, CDCl3): 7.39 – 7.25 (25H, m), 5.04 (1H, br.d, J 4.1 Hz), 4.98 (1H, br.s), 4.71 (1H, d, J 11.5 Hz), 4.69 (3H, br.s), 4.62 (1H, d, J 11.5 Hz), 
4.54 – 4.49 (5H, m), 4.33 (1H, br.d, J 1.3 Hz), 4.21 (2H, incl. br. d, J 6.0 Hz at 4.21), 4.18 – 4.12 (2H, incl. br. dd, J 4.3, 7.2 Hz at 4.15), 4.11 (1H, br.dd, J 3.6, 
7.9 Hz), 4.08 (1H, br.d, J 2.5 Hz), 4.05 (1H, dd, J 4.2, 6.6 Hz), 3.86 (1H, dd, J 5.2, 10.3 Hz), 3.82 – 3.76 (2H, incl. br. dd J 4.3, 9.7 Hz at 3.8), 3.66 – 3.58 (4H, incl. 
br. dd, J 4.7, 11.8 Hz at 3.6), 2.25 (2H, dt, J 0.9, 7.3 Hz), 1.36 – 1.18 (39H, m), 0.90 (3H, t, J 6.8 Hz); δC (101 MHz, CDCl3): 173.5, 138.3, 137.9, 137.7, 137.4, 
136.9, 128.5, 128.4, 128.3, 128.25, 128.1, 128.0, 127.9, 127.75, 127.7, 127.6, 127.55, 127.5, 106.0, 100.4, 85.1, 83.8, 83.5, 83.4, 82.5, 78.9, 73.3, 72.6, 72.4, 72.2, 
70.1, 67.2, 66.0, 62.3, 34.0, 31.9, 29.7, 29.65, 29.6, 29.5, 29.4, 29.3, 29.1, 24.8, 22.7, 14.1; νmax: 3414, 3062, 3032, 2915, 2852, 1737, 1467, 735, 697 cm-1. 
 
(ii) EDCI (5.5 mg, 0.035 mmol) in dry CH2Cl2 (1 mL) was added dropwise with stirring to the above furanoside (8.1 mg, 0.007 mmol), DMAP (4.3 mg, 
0.035 mmol) and (2R)-2-(1-((tert-butyldimethylsilyl)oxy)-16-((1S,2R)-2-((S)-20-methyl-19-oxooctatriacontyl)cyclopropyl)hexadecyl)hexa-cosanoic 
acid (14.3 mg, 0.010 mmol) (Mizutani et al., 1989) in dry CH2Cl2 (1 mL) at 0 °C under nitrogen. The mixture was stirred for 48 h, then worked 
up and purified as above affording the title compound (20) (11 mg, 63%) [Found (M+Na)+: 2485.0183; C160H272NaO15Si, requires: 2485.0188]; 
δH (400 MHz, CDCl3): 7.34 – 7.18 (25H, m), 4.99 (1H, br.d, J 4.2 Hz), 4.93 (1H, br.s), 4.65 (2H, d, J 11.5 Hz), 4.62 (2H, br.s), 4.56 (1H, d, J 11.6 
Hz), 4.51 – 4.43 (4H, m), 4.40 (1H, d, J 11.6 Hz), 4.31 (1H, br.d, J 2.0 Hz), 4.24 – 4.14 (4H, m), 4.13 – 4.00 (3H, m), 3.97 (1H, dd, J 4.5, 6.4 Hz), 
3.92 – 3.84 (2H, m), 3.80 (1H, dd, J 5.0, 10.4 Hz), 3.73 (1H, br.p, J 4.7 Hz), 3.58 – 3.53 (3H, incl. br.dd, J 4.3, 10.4 Hz at 3.56), 2.55 – 2.43 (2H, 
m), 2.37 (2H, t, J 7.5 Hz), 2.18 (2H, td, J 2.1, 7.3 Hz), 1.56 – 1.11 (182H, m), 1.01 (3H, d, J 6.9 Hz), 0.85 (9H, t, J 6.7 Hz), 0.81 (9H, s), 0.66 – 0.58 
(2H, m), 0.52 (1H, dt, J 3.9, 8.6 Hz), -0.01 (3H, s), -0.03 (3H, s), -0.37 (1H, br.q, J 5.1 Hz); δC (101 MHz, CDCl3): 215.2, 174.4, 173.3, 138.6, 138.3, 
137.8, 137.7, 137.4, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.8, 127.7, 127.65, 127.6, 127.55, 127.5, 127.4, 106.0, 100.3, 85.4, 84.7, 83.7, 
82.6, 80.1, 78.9, 77.1, 73.4, 73.2, 72.6, 72.5, 72.4, 72.2, 70.3, 67.2, 66.0, 64.2, 51.5, 46.3, 41.1, 34.0, 33.7, 33.0, 31.9, 30.2, 29.9, 29.7, 29.7, 
29.6, 29.55, 29.5, 29.45, 29.4, 29.35, 29.3, 29.1, 28.7, 27.7, 27.4, 27.3, 25.8, 24.8, 23.9, 23.7, 22.7, 16.4, 15.8, 14.1, 10.9, -4.4, -4.8; νmax: 3086, 
3061, 2923, 2851, 1737, 1715, 1464, 1117, 757, 697 cm-1. 
 
2.20     2',3'-Di-O-benzyl-L-glycerol-(1'→1)-2,3-di-O-benzyl-5-O-behenate-β-D-arabinofuranosyl-(1→2)-3-O-benzyl-5-O-(R)-2-((R)-1-hydroxy-16-((1S, 2R)-2-











The protected glycolipid α-D-arabinofuranoside (20) (10 mg, 0.004 mmol) was dissolved in dry THF (10 mL) in a dry polyethylene vial equipped 
with an acid proof rubber septum, followed by addition of pyridine (0.1 mL) at room temperature under nitrogen. The mixture was cooled to 0 
°C, and then hydrogen fluoride-pyridine complex as (70% w, 1.5 mL) was added dropwise. The mixture was stirred at 43 °C for 24 h, then 
neutralized by pouring it slowly into sat. aq. NaHCO3 and stirred until no more CO2 was liberated. The aqueous layer was re-extracted with 
chloroform (3×10 mL). The combined organic layers were evaporated; chromatography on silica eluting with hexane/ethyl acetate (10:1) afforded 
compound (21) as a colourless thick oil (6.5 mg, 68%) [NSI–Found (M+Na)+: 2371.9; C154H258NaO15, requires: 2371.9. NSI–Found (M+NH4)+: 
2367.0; C154H262NO15, requires: 2367.0]; δH (400 MHz, CDCl3): 7.36 – 7.23 (25H, m), 5.03 (1H, br.d, J 4.3 Hz), 4.97 (1H, br.s), 4.70 (2H, d, J 11.4), 
4.67 (1H, br.s), 4.65 (1H, d, J 11.9 Hz), 4.60 (1H, d, J 11.6 Hz), 4.56 – 4.49 (4H, m), 4.46 (1H, d, J 11.6 Hz), 4.34 (1H, br.d, J 1.7 Hz), 4.31 – 4.24 
(3H, incl. br. dd,  J 4.3, 8.1 Hz at 4.27), 4.22 (1H, br.dd, J 6.0, 8.6 Hz), 4.18 – 4.07 (4H, m), 4.07 – 4.00 (1H, m), 3.98 – 3.91 (1H, m), 3.85 (1H, dd, 
J 5.3, 10.2 Hz), 3.79 (1H, br.p, J 5.1 Hz), 3.65 – 3.55 (4H,  incl. br. dd,  J 4.4, 10.0 Hz at 3.60), 2.56 – 2.47 (1H, m), 2.44 – 2.38 (3H, m), 2.26 – 2.17 
(2H, m), 1.61 – 1.10 (182H, m), 1.06 (3H, d, J 6.9 Hz), 0.87 (9H, t, J 6.3 Hz), 0.69 – 0.63 (2H, m), 0.57 (1H, dt, J  4.1, 8.4 Hz), -0.32 (1H, br.q, J 5.1 
Hz); δC (101 MHz, CDCl3): 215.2, 175.0, 173.4, 138.5, 138.2, 137.8, 137.7, 137.3, 128.5, 128.4, 128.35, 128.3, 128.2, 128.1, 127.8, 127.75, 
127.7, 127.65, 127.6, 127.55, 127.5, 106.0, 100.4, 85.6, 84.6, 83.8, 82.6, 80.2, 78.9, 77.2, 73.4, 72.6, 72.5, 72.4, 72.3, 72.2, 70.2, 67.2, 66.0, 
63.7, 51.8, 46.3, 41.3, 41.1, 35.3, 34.0, 33.7, 33.0, 31.9, 30.2, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 29.1, 29.0, 28.7, 27.7, 27.4, 27.3, 25.6, 
24.8, 23.7, 22.7, 22.6, 20.4, 19.4, 16.4, 15.8, 14.3, 14.1, 11.4, 10.9; νmax: 3503, 3061, 2921, 2853, 1738, 1717, 1466, 1117, 758, 697 cm-1. 
 
2.21   L-glycerol-(1'→1)-5-O-behenate-β-D-arabinofuranosyl-(1→2)-5-O-(R)-2-((R)-1-hydroxy-16-((1S,2R)-2-((S)-20-methyl-19-oxoocta-
triacontyl)cyclopropyl)hexadecyl)hexacosanoate)-α-D-arabino-furanoside (22)  
Pd(OH)2-C/20% (20 mg) was added with stirring to furanoside (21) (R’  = H) (6.5 mg, 2.7 mmol) in CH2Cl2:MeOH:THF (2:1:1.5, 3 mL) at rt under 
hydrogen, then stirred for 36 h, filtered through celite and the solvent evaporated under reduced pressure.  Chromatography on silica eluting with 
chloroform/ methanol (10:1) gave (22) as a colourless thick oil (4.1 mg, 78%) [Found (M+Na)+: 1921.7019; C119H228NaO15, requires: 1921.7005]; δH 
(400 MHz, CDCl3+few drops CD3OD): 4.92 (1H, br.d, J 5.8 Hz), 4.91 (1H, br.s), 4.30 (1H, br.dd, J 2.4, 7.1 Hz), 4.28 (1H, br.d, J 2.7 Hz), 4.20 – 4.11 
(3H, m), 4.07 – 4.00 (3H, m), 3.97 (1H, br.q, J 5.2 Hz), 3.94 – 3.85 (4H, m), 3.52 – 3.46 (4H, m), 3.33 – 3.29 (3H, incl. br.dd, J 2.5, 4.1 Hz at 3.32), 
3.23 (1H, br.dd, J 2.9, 4.3 Hz), 2.49 – 2.39 (2H, m), 2.38 – 2.31 (4H, m), 2.30 – 2.23 (2H, m), 1.57 – 1.02 (181H, m), 0.97 (3H, d, J 6.8 Hz), 0.79 
(9H, t, J 6.9 Hz), 0.59 – 0.52 (2H, m), 0.48 (1H, dt, J 3.8, 11.8 Hz), -0.42 (1H, br.q, J 4.4 Hz); δC (101 MHz, CDCl3): 216.1, 175.0, 174.4, 105.8, 
101.6, 87.8, 80.3, 80.0, 77.2, 76.4, 75.4, 72.4, 70.4, 69.3, 65.7, 63.3, 63.1, 52.6, 46.2, 41.1, 34.7, 34.0, 32.9, 31.8, 30.1, 29.6, 29.5, 29.45, 29.4, 
29.35, 29.3, 29.25, 29.2, 29.15, 29.1, 29.0, 28.6, 27.3, 27.2, 25.3, 24.7, 23.6, 22.5, 16.2, 15.6, 13.9, 10.7; νmax: 3421,  2920, 2852, 1735, 1715, 
1468, 1121, 1045, 722 cm-1.  
 
 
3. Results and discussion 
The donor fragment 4, was prepared by known methods (Ishiwata et al., 2006). The acceptor fragment 5 was prepared as in Scheme 2. 
Compound 6 (Reddy et al., 2012; D’Souza et al., 2000) was subjected to a glycosidation reaction with 7 (Ashton et al., 1985) using N-
iodosuccinimide and silver triflate in dichloromethane at -35 °C to give the α- isomer 8 in 91% yield. The proton NMR of the product showed 
a downfield signal as a broad doublet at δ 4.98 (J 1.0 Hz), while the 13C NMR showed a peak at δ 105.6 due to the carbon at position 1, both 
indicating the α- anomer (Mizutani et al., 1989). Deprotection of the benzoyl group followed by protection of the resulting alcohol as an allyl 
ether using allyl bromide and sodium hydride, then removal of the silyl protecting group gave a diol at C-3 and C-5 positions in 63% overall 
yield. Two different groups were required at these positions in the DMAG’s acceptor. The presence of a p-methoxybenzyl group at the C-5 
position on the acceptor was found to give good β-selectivity  when coupling with the donor to form a disaccharide (Liu et al., 2010). Therefore, 
the primary alcohol was first protected as a TBDPS ether, while the secondary alcohol was protected with a benzyl group to give compound 
9. Replacement of the TBDPS group with a PMB group, followed by removal of the allyl group from C-2 led to the acceptor fragment 5 (Scheme 
2). The fragment 5 might be obtained in higher yield through the desilylation and debenzoylation of 8 followed by formation and nucleophilic 












             
Scheme 2: (i) 7, NIS/AgOTf, CH2Cl2, -35 °C, 91%; (ii) NaOCH3, CH3OH:CH2Cl2 (1:1), R.T., 1 h, 89%; (iii) NaH,  allyl bromide,  DMF, 0 °C /R.T., 1 h, 75%; (iv) TBAF, THF, 0 
°C /R.T., 16 h, 95%; (v) t-BuPh2SiCl, imidazole, DMF, 0 °C /R.T., 1/2 h, 65%; (vi) NaH, BnBr, DMF, 0 °C /R.T. 2 h, 72%; (vii) TBAF, THF, 0 °C /R.T.,16 h, 91%; (viii) NaH, 
PMBBr, DMF, 0 °C /R.T. 2 h, 76%; (ix) PdCl2, CH3OH:CH2Cl2 (1:1), R.T., 16 h, 84%. 
Coupling of arabinogylcerol 5 to arabinose 4 proceeded in high yield to give only the β-diastereomer at the newly formed acetal 10 (Scheme 
3). The proton NMR showed characteristic acetal signals at 4.96 (1H, br. s) and 4.79 (1H, br. d, J 4.3 Hz) for the pre-formed acetals; the 13C 
NMR showed signals at δ 106.2 and 100.6 corresponding to the α and β anomeric carbons respectively (Mizutani et al., 1989). With other 
combinations of protecting groups, such glycosylation reactions have been reported to produce mixtures of α and β isomers (Crich et al., 
2007; Liu et al., 2010). Ishiwata (Ishiwata et al., 2006) reported a strategy for β-selective glycosylation using donors protected with 3,5-TIDPS. 
An enhancement of β-selectivity was achieved by utilising a donor with an eight-membered ring protection as in 4. The best α/β-ratio of (1:20) 
from the disaccharide was realised.   By using a PMB protection in acceptor 5, we observed only the β-isomer. 
 
 
Scheme 3: Synthesis of 10, using NIS/AgOTf, molecular sieve, -78 °C, then Et3N, (86 %).  
The silyl groups were removed from compound 10. The resulting triol 11 was first converted into the diol by protection of the primary alcohol 
as a TBDPS ether, followed by benzylation of the secondary alcohols to give 12. Removal of the TBDPS group from the top primary alcohol to 
give 13, followed by removal of the PMB group from the lower primary alcohol gave diol 14. Compound 14 was converted into the 
corresponding dimesylate 15 and esterified with simple fatty acids, a model β-hydroxy-acid (Hameed, 2014), or a single synthetic methoxy-
MA (Baols, 2014), to give protected DMAGs compounds 16a-e, and after debenzylation, DMAGs 17a-e (Scheme 4). The sequence of 
deprotection and protection steps was chosen to overcome loss of selectivity in the acylation step, and also meant that the final deprotection 












Scheme 4:   (i) TBAF, THF, 0 °C /R.T., 6 h, 95%; (ii) t-BuPh2SiCl, imidazole, DMF, 0 °C /R.T., 2 h, 77%; (iii) NaH, BnBr, DMF, 0 °C /R.T., 2 h, 90%; (iv) TBAF, THF, 0 
°C /R.T., 6 h, 93%; (v) CAN/ CH3CN:H2O (9:1), 0 °C /R.T., 1 h, 89%; (vi) CH3SO2Cl, DMAP, pyridine, 16 h, 85%; (vii) RCOOH, CsHCO3, THF:DMF (5:1), 70 °C, 4 days, 
(a: 92%; b: 89%; c: 87%; d: 55%; e: 54%); (viii) (Pd(OH)2-C/20%), H2, CH3OH:CH2Cl2:THF (1:1:1.5), R.T., 36 h, (a: 82%; b: 81%; c: 87%; d: 74%; e: 73%). 
 
Alternatively, the diol 14 was coupled directly to protected synthetic MAs (Salah, 2013; Koza et al., 2009; Al-Dulayymi et al., 2005; Koza et 













Scheme 5: Synthesis of DMAG glycolipid: (i) RCOOH (R’ = TBDMS), EDCI, DMAP, CH2Cl2 (f: 97%; g: 84%; h: 91%); (ii) TBAF, THF (f: 38%; g: 64%; h: 31%);  (iii) 
(Pd(OH)2-C/20%), H2, CH3OH:CH2Cl2:THF (1:1:1.5), R.T., 36 h, (f: 71%; g: 70%; h: 72%). 
 
Using the intermediate alcohol 13, it was also possible to selectively esterify with different acids at each primary alcohol position of 
the DMAG sugar moiety.  Thus esterification of 13 led to a mono-acyl diarabinoglycerol 19, esterified only on the top arabinose, which 
could then be selectively deprotected and acylated on the lower arabinose to give 22 (R’ = H) (Scheme 6). 
 
Scheme 6: (i) Behenic acid, EDCI, DMAP, CH2Cl2, 0 °C, 48 h, 85%; (ii) CAN/ CH3CN:H2O:THF (9:1:0.2), 0 °C /R.T., 16 h, 62%; (iii) RCOOH (R’ = TBDMS), EDCI, DMAP, 
CH2Cl2, 0 °C, 48 h, 63%; (iv) HF-pyridine complex, pyridine, THF, 43 °C, 24 h, 68%; (v) (Pd(OH)2-C/20%), H2, CH3OH:CH2Cl2:THF (1:2:1.5), R.T., 36 h, 78%.   
 
Product 16c was converted into its penta-acetate (23) (Table 1) by reaction with acetic anhydride in pyridine. The NMR spectra of this 
(Supplementary Information) could then be compared directly with those reported for the penta-acetate of the natural mixture (Elass-
Rochard et al., 2012). As seen in Table 1, there is a very good agreement between the signals for the diarabinoglycerol fragments of natural 












 By appropriate use of protecting groups, the skeleton of diarabinoglycerol can be produced with essentially complete 
stereocontrol. Esterification with simple fatty acids or with individual mycolic acids provides the corresponding diacyl- and 
dimycoloyl diarabinoglycerols. The NMR spectra of these, in the sugar region, match very well to those reported for natural 
mixtures, confirming the stereochemistry of the arabinose units and establishing the absolute stereochemistry of the glycerol unit. 
These compounds will allow the effect of the detailed structure of DMAG on its biological activity to be determined. 
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C1’ 65.3 3.60 (dd, J 4.5, 
11.0), 
3.80 (dd, J 5.2, 
11.0) 
3.60 (dd, J 
4.5, 11.0), 
3.80 (dd, J 
5.2, 11.0) 
65.3 
C2’ 69.8 5.20 5.21(m) 69.8 
C3’ 62.8 4.25 (dd, J 4.0, 
11.7), 
4.17 (dd, J 5.2, 
11.7) 












C1 99.5 5.39 (d, J 4.7) 5.40 (br.d, J 
4.7) 
99.4 
C2 77.2 4.98 (dd, J 4.7, 
6.6) 
4.95 (br.dd, 
J 4.7, 6.6) 
77.5 
C3 75.4 5.34 (dd, J 5.1, 
6.6) 
5.34 (dd, J 
5.3, 6.3) 
75.6 
C4 79.0 4.12 (dt, J 4.6, 
5.1, 7.8) 
4.12 (m) 79.1 
C5 65.2 4.38 (dd, J 4.6, 
11.6), 















 C1 105 4.91 (s) 4.91 (br.s) 105 












Table 1: Comparison of diarabinoglycerol fragment of carbon and proton 





C3 77.5 4.98 4.95 (br.dd, 
J 4.7, 6.6) 
77.5 
C4 80.8 4.17 4.17 (m) 80.6 
C5 63.8 4.18, 4.30 
(dd, J 2.7,10.3) 
4.18 (m) 63.6 
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